1,646
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours

, , , , &
Pages 823-828 | Received 30 Apr 2011, Accepted 18 May 2011, Published online: 18 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Mette Marie Fode, Kirstine Bak-Fredslund, Jørgen Baltzer Petersen, Esben Worm, Michael Sørensen & Morten Høyer. (2017) A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose. Acta Oncologica 56:11, pages 1614-1620.
Read now
Constantin Dreher, Katrine I. Høyer, Mette Marie Fode, Daniel Habermehl, Stephanie E. Combs & Morten Høyer. (2016) Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma. Acta Oncologica 55:7, pages 886-891.
Read now
Ja Young Kim, Young Kyung Lim, Tae Hyun Kim, Kwang Hyun Cho, Sang Hyoun Choi, Hojin Jeong, Dae Woong Kim, Jung Hoon Park, Dong Ho Shin, Se Byeong Lee, Sang Soo Kim, Joo-Young Kim, Dae Yong Kim & Joong-Won Park. (2015) Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy. Acta Oncologica 54:10, pages 1827-1832.
Read now
Esben S. Worm, Morten Høyer, Walther Fledelius, Anders T. Hansen & Per R. Poulsen. (2013) Variations in magnitude and directionality of respiratory target motion throughout full treatment courses of stereotactic body radiotherapy for tumors in the liver. Acta Oncologica 52:7, pages 1437-1444.
Read now
Morten Høyer & Ludvig P. Muren. (2012) Stereotactic body radiation therapy – A discipline with Nordic origin and profile. Acta Oncologica 51:5, pages 564-567.
Read now

Articles from other publishers (37)

David A. Bush, Michael Volk, Jason C. Smith, Mark E. Reeves, Samrat Sanghvi, Jerry D. Slater & Michael deVera. (2023) Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial. Cancer 129:22, pages 3554-3563.
Crossref
Kanokphorn Thonglert, Michael D. Chuong, Robert Herrera & Smith Apisarnthanarax. (2023) Advanced and emerging radiation therapy approaches for intrahepatic cholangiocarcinoma. Hepatoma Research.
Crossref
Takuto Nosaka, Hidetaka Matsuda, Ryotaro Sugata, Yu Akazawa, Kazuto Takahashi, Tatsushi Naito, Masahiro Ohtani, Kazuyuki Kinoshita, Tetsuya Tsujikawa, Yoshitaka Sato, Yoshikazu Maeda, Hiroyasu Tamamura & Yasunari Nakamoto. (2023) Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma. Current Oncology 30:4, pages 3915-3926.
Crossref
Jong Yun Baek, Do Hoon Lim, Dongryul Oh, Heerim Nam, Jae J Kim, Jun Haeng Lee, Byung-Hoon Min & Hyuk Lee. (2022) Increased Risk of Diabetes after Definitive Radiotherapy in Patients with Indolent Gastroduodenal Lymphoma. Cancer Research and Treatment 54:1, pages 294-300.
Crossref
Esben Schjødt Worm, Rune Hansen, Morten Høyer, Britta Weber, Hanna Mortensen & Per Rugaard Poulsen. (2021) Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulations. Physics in Medicine & Biology 66:20, pages 205009.
Crossref
Francesco Fracchiolla, Francesco Dionisi, Roberto Righetto, Lamberto Widesott, Irene Giacomelli, Giorgio Cartechini, Paolo Farace, Mattia Bertolini, Maurizio Amichetti & Marco Schwarz. (2021) Clinical implementation of pencil beam scanning proton therapy for liver cancer with forced deep expiration breath hold. Radiotherapy and Oncology 154, pages 137-144.
Crossref
Jacob S. Parzen, William Hartsell, John Chang, Smith Apisarnthanarax, Jason Molitoris, Michael Durci, Henry Tsai, James Urbanic, Jonathan Ashman, Carlos Vargas, Craig Stevens & Peyman Kabolizadeh. (2020) Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group. Radiation Oncology 15:1.
Crossref
Saira E. Alex, Eric D. Brooks & Emma B. Holliday. (2019) Proton therapy for colorectal cancer. Applied Radiation Oncology, pages 18-22.
Crossref
Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng & Sung-Hsin Kuo. (2019) Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness. World Journal of Gastrointestinal Oncology 11:8, pages 579-588.
Crossref
Awalpreet S. Chadha, Jillian R. Gunther, Cheng-En Hsieh, Maureen Aliru, Lakshmi S. Mahadevan, Bhanu P. Venkatesulu, Christopher H. Crane, Prajnan Das, Joseph M. Herman, Eugene J. Koay, Cullen Taniguchi, Emma B. Holliday, Bruce D. Minsky, Yelin Suh, Peter Park, Gabriel Sawakuchi, Sam Beddar, Bruno C. Odisio, Sanjay Gupta, Evelyne Loyer, Harmeet Kaur, Kanwal Raghav, Milind M. Javle, Ahmed O. Kaseb & Sunil Krishnan. (2019) Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiotherapy and Oncology 133, pages 54-61.
Crossref
Anders Lideståhl, Gracinda Mondlane, Michael Gubanski, Pehr A. Lind & Albert Siegbahn. (2019) An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours. Physica Medica 60, pages 120-126.
Crossref
Piotr Spychalski, Jarek Kobiela, Magdalena Antoszewska, Agata Błażyńska-Spychalska, Barbara A. Jereczek-Fossa & Morten Høyer. (2019) Patient specific outcomes of charged particle therapy for hepatocellular carcinoma – A systematic review and quantitative analysis. Radiotherapy and Oncology 132, pages 127-134.
Crossref
Sahin Lacin, Asif Rashid, Yun Shin Chun, Bruno Calazans Odisio, Eugene J. Koay, Reham Abdel-Wahab & Ahmed O. Kaseb. 2019. Textbook of Gastrointestinal Oncology. Textbook of Gastrointestinal Oncology 207 234 .
Arpit M. Chhabra, Melissa A. Frick, Tejan Diwanji, Jason K. Molitoris & Charles B. SimoneIIII. 2019. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy 217 233 .
Eugene J. Koay, Dawn Owen & Prajnan Das. (2018) Radiation-Induced Liver Disease and Modern Radiotherapy. Seminars in Radiation Oncology 28:4, pages 321-331.
Crossref
W. Tristram Arscott, Reid F. Thompson, Lingshu Yin, Brendan Burgdorf, Maura Kirk & Edgar Ben-Josef. (2018) Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications. Physics and Imaging in Radiation Oncology 8, pages 17-22.
Crossref
Benjamin O. Spieler, Lorraine Portelance & Eric A. Mellon. (2018) Stereotactic ablative radiation therapy in the treatment of liver tumors. Applied Radiation Oncology, pages 17-23.
Crossref
Stephanie K. Schaub, Pehr E. Hartvigson, Michael I. Lock, Morten Høyer, Thomas B. Brunner, Higinia R. Cardenes, Laura A. Dawson, Edward Y. Kim, Nina A. Mayr, Simon S. Lo & Smith Apisarnthanarax. (2018) Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies. Technology in Cancer Research & Treatment 17, pages 153303381879021.
Crossref
Smith Apisarnthanarax, Rosanna Yeung, Stephen Bowen & Tobias R. Chapman. 2018. Gastrointestinal Malignancies. Gastrointestinal Malignancies 171 195 .
Thomas Henry, Ana Ureba, Alexander Valdman & Albert Siegbahn. (2016) Proton Grid Therapy: A Proof-of-Concept Study. Technology in Cancer Research & Treatment 16:6, pages 749-757.
Crossref
Gracinda Mondlane, Michael Gubanski, Pehr A. Lind, Ana Ureba & Albert Siegbahn. (2017) Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases. Physica Medica 42, pages 263-270.
Crossref
Morten Høyer. 2017. Radiation Therapy for Liver Tumors. Radiation Therapy for Liver Tumors 245 256 .
Gracinda Mondlane, Michael Gubanski, Pehr A. Lind, Thomas Henry, Ana Ureba & Albert Siegbahn. (2016) Dosimetric Comparison of Plans for Photon- or Proton-Beam Based Radiosurgery of Liver Metastases. International Journal of Particle Therapy 3:2, pages 277-284.
Crossref
Nitin Ohri, Laura A. Dawson, Sunil Krishnan, Jinsil Seong, Jason C. Cheng, Shiv K. Sarin, Milan Kinkhabwala, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman & Chandan Guha. (2016) Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study. Journal of the National Cancer Institute 108:9, pages djw133.
Crossref
Si-Yuan Zhang, Guang-Ying Zhu, Gong Li, Yi-Bao Zhang & Jian-Hao Geng. (2016) Application of stereotactic body radiation therapy to cancer liver metastasis. Cancer Letters 379:2, pages 225-229.
Crossref
David A. Bush, Jason C. Smith, Jerry D. Slater, Michael L. Volk, Mark E. Reeves, Jason Cheng, Roger Grove & Michael E. de Vera. (2016) Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis. International Journal of Radiation Oncology*Biology*Physics 95:1, pages 477-482.
Crossref
Joachim Widder, Arjen van der Schaaf, Philippe Lambin, Corrie A.M. Marijnen, Jean-Philippe Pignol, Coen R. Rasch, Ben J. Slotman, Marcel Verheij & Johannes A. Langendijk. (2016) The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine. International Journal of Radiation Oncology*Biology*Physics 95:1, pages 30-36.
Crossref
Isabelle Thibault, Matt Wronski, Renée Korol, William Chu, Joelle Helou, Darby Erler & Hans T. Chung. (2015) Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for liver stereotactic ablative body radiotherapy. Journal of Radiation Oncology 5:1, pages 63-69.
Crossref
Kengo Ohta, Masashi Shimohira, Shigeru Sasaki, Hiromitsu Iwata, Hiroko Nishikawa, Hiroyuki Ogino, Masaki Hara, Takuya Hashizume & Yuta Shibamoto. (2014) Transarterial Fiducial Marker Placement for Image-guided Proton Therapy for Malignant Liver Tumors. CardioVascular and Interventional Radiology 38:5, pages 1288-1293.
Crossref
Saumil J. Gandhi, Xing Liang, Xuanfeng Ding, Timothy C. Zhu, Edgar Ben-Josef, John P. Plastaras, James M. Metz, Stefan Both & Smith Apisarnthanarax. (2015) Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons. Practical Radiation Oncology 5:4, pages 209-218.
Crossref
Xing-Qi Lu. 2015. Stereotactic Body Radiotherapy. Stereotactic Body Radiotherapy 27 43 .
Dong Wook Kim, Kwangzoo Chung, Weon Kuu Chung, Sun Hyun Bae, Dong Oh Shin, Seongeon Hong, Sung Ho Park, Sung-Yong Park, Chae-Seon Hong, Young Kyung Lim, Dongho Shin, Se Byeong Lee, Hyun-ho Lee, Jiwon Sung & Myonggeun Yoon. (2014) Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma. Radiation Oncology 9:1.
Crossref
Francesco Dionisi & Edgar Ben-Josef. (2014) The Use of Proton Therapy in the Treatment of Gastrointestinal Cancers. The Cancer Journal 20:6, pages 371-377.
Crossref
Chie Toramatsu, Norio Katoh, Shinichi Shimizu, Hideaki Nihongi, Taeko Matsuura, Seishin Takao, Naoki Miyamoto, Ryusuke Suzuki, Kenneth Sutherland, Rumiko Kinoshita, Rikiya Onimaru, Masayori Ishikawa, Kikuo Umegaki & Hiroki Shirato. (2013) What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy. Radiation Oncology 8:1.
Crossref
Santosh YajnikSantosh Yajnik. 2013. Proton Beam Therapy. Proton Beam Therapy 13 29 .
Ted C. Ling, Joseph I. Kang, David A. Bush, Jerry D. Slater & Gary Y. Yang. (2013) Proton therapy for hepatocellular carcinoma. Chinese Journal of Cancer Research 24:4, pages 361-367.
Crossref
Hiroki Shirato, Rikiya Onimaru, Masayori Ishikawa, Jun-ichi Kaneko, Tsuguhide Takeshima, Kenta Mochizuki, Shinichi Shimizu & Kikuo Umegaki. (2012) Real-time 4-D radiotherapy for lung cancer. Cancer Science 103:1, pages 1-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.